TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics ...

Insiders sold more Tempus AI (TEM) stock last week as shares of the medical technology firm continue to notch a series of fresh all-time highs.

TD Cowen believes this acquisition positions Tempus AI for enhanced product offerings and entry into new markets, as Ambry Genetics brings a profitable germline testing laboratory with over $300 ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

The Red Cross voiced alarm Tuesday over the risk that fighting in the besieged DR Congo city of Goma could cause samples of Ebola and other pathogens held in a laboratory to escape. The ...

China on Monday dismissed the possibility that the virus that caused COVID-19 leaked from a lab, after the CIA said it now favors the so-called lab leak theory over natural transmission.

Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14, 2024 ...

The CIA now believes the virus responsible for the COVID-19 pandemic most likely originated from a laboratory, according to an assessment released Saturday that points the finger at China even ...

In this article, we are going to take a look at where Tempus AI (NASDAQ:TEM) stands against the other stocks. Stock gains always get people talking, and 2025 is no exception. Markets have moved ...

The CIA announced that they believe that the COVID-19 virus likely originated from an accidental lab leak in China instead of it occurring naturally. The governmental organization released a ...

The CIA on Saturday offered a new assessment on the origin of the Covid outbreak, saying the coronavirus is "more likely" to have leaked from a Chinese lab than to have come from animals.